Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain

CompletedOBSERVATIONAL
Enrollment

305

Participants

Timeline

Start Date

July 18, 2021

Primary Completion Date

September 17, 2021

Study Completion Date

October 19, 2021

Conditions
SARS-CoV 2 InfectionCovid19
Interventions
BIOLOGICAL

BBIBP-CorV

Inactivated virus COVID-19 vaccine

BIOLOGICAL

BNT162b2

mRNA-based COVID-19 vaccine

Trial Locations (1)

Unknown

Royal College of Surgeons in Ireland - Bahrain, Manama

All Listed Sponsors
collaborator

The National Taskforce for Combatting COVID-19- Kingdom of Bahrain

UNKNOWN

collaborator

Bahrain Defence Force Royal Medical Services

UNKNOWN

collaborator

Ministry of Health, Bahrain

OTHER_GOV

collaborator

Bahrain International Exhibition & Convention Centre

UNKNOWN

lead

Royal College of Surgeons in Ireland - Medical University of Bahrain

OTHER

NCT04993560 - Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain | Biotech Hunter | Biotech Hunter